Hims & Hers Health faces securities class action lawsuit

The Rosen Law Firm has initiated a class action lawsuit against Hims & Hers Health, Inc., alleging the company made materially false and misleading statements to shareholders between August 4, 2025, and July 29, 2026. The litigation centers on claims that the company shared private consumer health data with third-party advertising platforms without adequate disclosure.

According to the complaint, the company allegedly billed customers for prescriptions immediately upon the submission of an intake form, despite claiming that patients would consult with a medical provider to determine appropriate treatments. These practices, the lawsuit contends, subjected the firm to undisclosed regulatory scrutiny and potential financial penalties.

Investors who purchased Hims securities during the specified period must file for lead plaintiff status by November 2, 2026. As the class has not yet been certified, individual investors are not currently represented by counsel unless they specifically retain one.